Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Jul 26, 2018 Life Science
I-Mab Out-Licenses Bi-Specific to South Korea’s ABL Bio in $100 Million Deal Jul 26, 2018 Life Science
KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma Jul 26, 2018 Life Science
Life Science & Technology Weekly 153 – Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Jul 26, 2018 Life Science, Technology
GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research Jul 25, 2018 Life Science
Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Jul 25, 2018 Life Science
Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio Jul 24, 2018 Life Science
Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan Jul 24, 2018 Life Science
Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Jul 24, 2018 Life Science
Maple Leaf Green World Inc. Announces Cultivation and Extraction Teams in British Columbia and Nevada Jul 24, 2018 Life Science
